Osteoscan en es it fr

Osteoscan Brand names, Osteoscan Analogs

Osteoscan Brand Names Mixture

  • No information avaliable

Osteoscan Chemical_Formula


Osteoscan RX_link


Osteoscan fda sheet

Osteoscan msds (material safety sheet)

Osteoscan Synthesis Reference

No information avaliable

Osteoscan Molecular Weight

391.46 g/mol

Osteoscan Melting Point

No information avaliable

Osteoscan H2O Solubility

10 mg/L

Osteoscan State


Osteoscan LogP


Osteoscan Dosage Forms

Tablets (100 mg)

Osteoscan Indication

For symptomatic relief of dysuria, urgency, nocturia, suprapubic pain, frequency and incontinence as may occur in cystitis, prostatitis, urethritis, urethrocystitis/urethrotrigonitis.

Osteoscan Pharmacology

Flavoxate is a spasmolytic flavone derivative that acts by relaxing the smooth muscle in the urinary tract. Flavoxate is a competitive muscarinic receptor antagonist indicated for the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency, and urinary frequency. Muscarinic receptors play an important role in several major cholin-ergically mediated functions, including contractions of urinary bladder smooth muscle and stimulation of salivary secretion.

Osteoscan Absorption

Well absorbed from gastrointestinal tract.

Osteoscan side effects and Toxicity

The oral LD50 for flavoxate HCl in rats is 4273 mg/kg. The oral LD50 for flavoxate HCl in mice is 1837 mg/kg. Symptoms of overdose include convulsions, decreased ability to sweat, (warm, red skin, dry mouth, and increased body temperature), hallucinations, increased heart rate and blood pressure, and mental confusion.

Osteoscan Patient Information

Osteoscan Organisms Affected

Humans and other mammals